<qa>  What is the name of the study that is open-labeled to assess the safetyThis is an open-label study to assess the safety, tolerability, efficacy and pharmacokinetics of eteplirsen in patients with early stage Duchenne muscular dystrophy DMD who are amenable to exon 51 skipping. 